WO2014029013A1 - Method for producing silver(i) orthoperiodates - Google Patents

Method for producing silver(i) orthoperiodates Download PDF

Info

Publication number
WO2014029013A1
WO2014029013A1 PCT/CA2013/000735 CA2013000735W WO2014029013A1 WO 2014029013 A1 WO2014029013 A1 WO 2014029013A1 CA 2013000735 W CA2013000735 W CA 2013000735W WO 2014029013 A1 WO2014029013 A1 WO 2014029013A1
Authority
WO
WIPO (PCT)
Prior art keywords
silver
periodate
hydroxide
source
solution
Prior art date
Application number
PCT/CA2013/000735
Other languages
French (fr)
Inventor
Patricia L. Nadworny
Graeme PROSPERI-PORTA
Kevin R. UNRAU
Original Assignee
Innovotech, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innovotech, Inc. filed Critical Innovotech, Inc.
Publication of WO2014029013A1 publication Critical patent/WO2014029013A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A01N59/16Heavy metals; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/46Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16Biologically active materials, e.g. therapeutic substances
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09DCOATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D5/00Coating compositions, e.g. paints, varnishes or lacquers, characterised by their physical nature or the effects produced; Filling pastes
    • C09D5/14Paints containing biocides, e.g. fungicides, insecticides or pesticides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A61L2300/104Silver, e.g. silver sulfadiazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2420/00Materials or methods for coatings medical devices
    • A61L2420/02Methods for coating medical devices

Definitions

  • This invention relates to methods for producing anti-microbial silver compounds, preferably silver (I) periodates.
  • the invention also includes the silver compounds produced by the process of the invention.
  • Silver and silver ions have long been known for their anti-bacterial properties. More recently, this use has extended to treating biofilms and to their incorporation as antimicrobial agents in medical devices and wound dressings.
  • compositions and methods of the present invention comprise one or more silver (I) periodate compounds or compositions, their methods of synthesis, and their use as antimicrobial agents.
  • This invention provides several methods for producing or synthesizing Ag 5 l0 6 and Ag 2 H 3 l06.
  • compositions and methods of the present invention comprise silver ions or complexes containing silver as the antimicrobial agent. These silver-containing agents are the active agents in antimicrobial compositions.
  • the silver compounds are one or more silver (I) periodates.
  • compositions and methods of the present invention have applicability wherever the presence of an antimicrobial agent is effective and/or beneficial.
  • these antimicrobial agents may be used in a wide variety of agricultural, industrial, and medical environments, e.g., disinfecting any surface, particularly disinfecting work or processing surfaces (e.g., tables); in antimicrobial coatings; in medical devices and implants, particularly where having an antimicrobial property or characteristic would be beneficial; and in treating human, plant, and animal diseases and conditions.
  • the compositions and methods of the present invention are also effective in treating and/or eradicating biofilm.
  • compositions and methods of the present invention are thermally stable and are not inactivated as quickly as typical ionic silver when placed in contact with compounds that typically inactivate silver ions, e.g., chlorides, sulphides, sulphates, carbonates, thiosulfates, bromides, and iodides.
  • the compounds of the present invention also are not inactivated when exposed to a biological fluid, e.g., urine, feces, mucin, or blood. That is, the silver ions of the present invention retain their antimicrobial activity for periods of time in environments that would typically inactivate other silver containing agents.
  • the present invention is a process for producing a silver (I) periodate comprising mixing in an aqueous solution a hydroxide; a periodate; and a source of single valency silver ions; and allowing the silver (I) periodate to form.
  • the hydroxide is potassium hydroxide
  • the periodate is potassium meta-periodate
  • the source of silver is silver nitrate.
  • the compounds produced by the process of the present invention include, but are not limited to, a silver-containing chemical substance, compound, or complex that exhibits antimicrobial activity, and is Ag (I) combined with a higher oxidation state iodine and coordinated with oxygen atoms.
  • the cation can be any of a large number of cations.
  • Exemplary cations include but are not limited to K, Na, Mg, Ca, Au, Pt, Cu, Zn, and Fe.
  • the preferred cations are K and Na.
  • the preferred compounds are Ag 5 l0 6 and Ag 2 H 3 l0 6l and compositions containing one or both of these compounds.
  • the compound may be anhydrous or a hydrate.
  • compositions and methods of the present invention are antimicrobial, e.g. against biofilms, similar structures, or precursors formed by bacteria, fungi, viruses, algae, parasites, yeasts, and/or other microbes.
  • the antimicrobial effectiveness also applies to planktonic microorganisms.
  • the invention also includes an improved process for producing silver compounds, including, but not limited to, the silver (I) periodate compounds of the present invention.
  • the silver (I) periodate compounds of the present invention may be produced by mixing, in an aqueous solution: 1) a hydroxide; 2) a source of iodine, e.g., a periodate; and 3) a source of silver.
  • the hydroxide is potassium hydroxide;
  • the source of iodine is potassium meta-periodate;
  • the source of silver is silver nitrate.
  • water may be used in the processes of the present invention, including but not limited to deionized, reverse osmosis, distilled, double distilled, and milli-q. The preferred water is deionized or double deionized.
  • the silver (I) periodates of the present invention may be formed by mixing the primary ingredients in any ratio suitable for the specific reagents used and/or for the desired product, e.g., a ratio from about X:Y:Z to about X':Y':Z' (where X and X' is the relative amount of the source of silver; where Y and Y' is the relative amount of the hydroxide; and where Z and Z' is the relative amount of the source of iodine).
  • X, X', Y, Y', Z, and Z' may be integers or any fraction of an integer.
  • the ratio may be from about 1 :8:2 to about 8:1 :0.5.
  • the preferred ratio range is from about 1 :2.6:0.72 to about 7:2.5:1 , and the most preferred range is from about 1 :1.1 :0.4 to about 1.0.7:0.24.
  • Example 3 the inventors have found that 100% pure Ag 5 l0 6 may be formed using 5.7 g AgN0 3 , 5.1 g KOH, and 1.8 g KI0 4 , which corresponds to a weight ratio of 1 :0.89:0.32.
  • the silver (I) periodates of the present invention may be formed by mixing: source of silver, from about 10 grams to about 80 grams; hydroxide, from about 10 grams to about 80 grams; and periodate, from about 5 grams to about 20 grams.
  • source of silver from about 10 grams to about 80 grams
  • hydroxide from about 10 grams to about 80 grams
  • periodate from about 5 grams to about 20 grams.
  • the silver (I) periodates of the present invention may be formed by mixing: source of silver, from about 25 grams to about 70 grams; hydroxide, from about 25 grams to about 65 grams; and periodate, from about 10 grams to about 18 grams.
  • the silver (I) periodates of the present invention may be formed by mixing: source of silver, from about 40 grams to about 50 grams; hydroxide, from about 35 grams to about 45 grams; and periodate, from about 12 grams to about 16 grams.
  • the amount of each raw material may be scaled up or down from the base quantity by multiplying each base quantity by a standard scale factor (SF).
  • SF standard scale factor
  • Base quantities that have been found to be effective are: silver nitrate, 45.6 g; potassium hydroxide, 40.8 g; potassium meta-periodate, 14.4 g; and De-ionized water, 250 ml_ It is intended that the present invention should not be limited to these specific amounts; they represent the relative proportions found to be effective using the least amount of silver nitrate in a process in which all of the silver reacted (for cost savings purposes).
  • This proportion also results in 100% purity product.
  • One skilled in the art will recognize that changing one or more of the proportions may result in all of the silver reacting, but other side reactions may occur (e.g., KN0 3 formation). For example, decreasing the amount of KOH or KI0 4 may result in some of the AgN0 3 not reacting.
  • the invention therefore includes other reactions, e.g., where purity of the resulting product and/or unreacted silver is acceptable.
  • exemplary other parameters include but are not limited to mixing time, stirring rate, temperature, pressure, drying time, and pH. It is believed that temperature and pressure may not be critical - room temperature and pressure have been shown to be effective in the synthesis processes shown in the Examples.
  • the drying time and method may be related to the consistency of the final product - the final product may hold excess water if not well dried. With lower water volumes, the inventors have found stirring rate and time may affect the final grain size, e.g., a longer stirring time may result in larger grain size.
  • pH does not need to be controlled, and that varying the pH to achieve a desired product is well within the skill in the art.
  • the process includes KOH and is a highly basic reaction
  • the typical product is Ag 5 l0 6 .
  • KOH is not present and the reaction is acidic/neutral, the product tends to be Ag 2 H 3 l0 6 .
  • the pH is between these two, a mixture of Ag 5 l0 6 and Ag 2 H 3 l0 6 tends to be produced.
  • a minimum stirring time is one that is sufficient to ensure that the reaction is complete, a time that is variable depending on the type and amount of reagents. Determining all of these parameters is well known to those with skill in the art.
  • Some embodiments of the invention include a source of single valency silver ions selected from the group consisting of silver nitrate; any silver compound soluble in aqueous solution; or combinations thereof.
  • the present invention relates to an article of manufacture which comprises the antimicrobial compositions of the present invention.
  • the composition is used to form an article or a portion of the article, for example by molding, casting, extruding, etc.
  • at least part of the formed article is composed of one or more of the compositions of the present invention, alone or in admixture with other components.
  • the composition is applied to a preformed article or part of an article as a coating.
  • the coated article may be produced, for example, by dipping the article into the composition or by spraying the article with the composition and then drying the coated article.
  • the compositions are used to coat medical devices by reaction of one silver iodate (e.g. sodium diperiodatoargentate and/or potassium diperiodatoargentate) to form another (e.g. pentasilver hexaoxoiodate) in the presence of the device to be coated.
  • the silver iodate is formed from silver nitrate, potassium hydroxide, and potassium meta-periodate in the presence of the device to be coated.
  • the silver iodate is pre-synthesized as a powder using one of the above methods, and is then incorporated into or coated onto the device.
  • the starting compounds used to form the silver iodates are produced by an aqueous solution of a monovalent silver salt or a silver complex such as silver nitrate, in the presence of a periodate such as potassium meta-periodate, with or without potassium hydroxide, depending on the desired silver iodate compound.
  • a periodate such as potassium meta-periodate
  • Inclusion of the base causes formation of compounds such as Ag 5 l0 6
  • exclusion of the base causes formation of compounds such as Ag 2 H 3 l0 6 .
  • silver iodates such as pentasilver hexaoxoiodate, can be formed by hydrothermal reaction of compounds such as sodium or potassium diperiodatoargentate (III), or combinations thereof.
  • the reaction products of the present invention are typically formed in an aqueous solution. If formed from silver nitrate, potassium meta-periodate, and potassium hydroxide, this reaction can be performed at room temperature. If formed from potassium and/or sodium diperiodatoargentate (III), the reaction rate can be increased by heating the solution. While not intending to limit the invention to a particular temperature or temperature range, the reaction products of the present invention may be formed by heating the solution up to about 400°C, preferably in a range from about room temperature to about 150°C, preferably in a range from about 70°C to about 120°C.
  • the reaction products of the present invention may be formed at 80°C under ambient conditions or may be formed at 120°C under pressure (e.g., in an autoclave).
  • compositions of the present invention may be used with or incorporated into an article where antimicrobial properties are desirable and/or beneficial.
  • the present invention also may provide compositions that provide antimicrobial, antibacterial, antiviral, or antifungal activity, or some combination thereof. Examples include, but are not limited to, medical and surgical devices and/or environments, such as catheters or implants. Other uses will be readily evident to those skilled in the art.
  • compositions of the present invention may be used wherever biofilm or similar structures may be found, including but not limited to microorganisms growing and/or floating in liquid environments, particularly flowing liquids.
  • Additional inactive ingredients may be optionally incorporated in the formulations, or added to the formulation, based on the intended use. Those skilled in the art will readily recognize that there are a wide variety of additional ingredients that may be added to a composition of the present invention, including but not limited to emulsifiers, thickening agents, solvents, anti-foaming agents, preservatives, fragrances, coloring agents, emollients, fillers, and the like.
  • stirring rate is a function of the batch size and stirrer. The operator may choose a stirring rate that causes the solution to generate a vortex and create an even mixture.
  • steps 3-5 are optional additional steps.
  • the filter cake should be dried (e.g., pulled dry) until no more water comes through the filter and the cake appears relatively dry. This time may be variable, and is typically from about 15 minutes to about the time calculated in step 1. Note: This method should not result in any N0 3 in the final product. However, if the product shows signs of white crystal formation, the product should be washed with additional ddH 2 0 and re-dried as described above. Operation #7
  • This step may be started while the product is drying.
  • the purpose of this example was to determine whether Ag 5 l0 6 synthesized from potassium or sodium diperiodatoargentate (III) and Ag 5 l0 6 synthesized directly were of equivalent purity, and to compare their properties.
  • the solution can be heated in an oven at, for example, 80°C, at room pressure, but the process takes longer to provide the same material.
  • the sample was placed in a tared watch glass, placed in the fume hood, and covered, but not sealed and left to dry overnight.
  • the sample was transferred into a vial and the vial was stored in a sealed container with a desiccant.
  • the direct method yields at least twice the Ag 5 l0 6 per molecule of silver used.
  • the sample was placed in a watch glass in the fume hood to dry overnight, and covered, but not sealed.
  • the sample was transferred to a vial and placed into a sealed container with a desiccant.
  • the product achieved in Run 1 was 97.4 wt% Ag 2 H 3 l0 6 (pale yellow product), and 2.6 wt% Ag 5 l0 6 (dark brown product which formed on washing to a higher pH), as determined by XRD.
  • the ratio of reagents used should be5.1 g KOH : 1.8g KI0 4 : 5.7g AgN0 3 .
  • the stirring time could be reduced to 10 minutes without impacting the yield or purity.
  • the purpose of this example is to determine whether Ag 5 l0 6 , currently synthesized following Example 1 , can be made using a lower starting volume of water.
  • Example 1 The method that is used in Example 1 may use large volumes of water to generate the Ag 5 l0 6 . It was determined that significantly reducing the water volume resulted in the presence of KI0 4 , one of the starting products, in the final product, due to its relatively low solubility. Although it initially dissolved at lower water volumes, it appeared that when the AgN0 3 was added to the solution, the higher ionic strength of the solution caused the KI0 4 to precipitate out before it had a chance to react with the AgN0 3 . There did appear to be some room for reduction of the starting water volume, which would be very valuable for potential future commercial-scale production. The purpose of this study is to determine how much the starting water volume can be reduced (if at all) without impacting the purity of the final product.
  • Example 1 A batch was generated following Example 1 at a scale factor of 1/5 (i.e. starting with 9.12g AgN0 3 , etc.), but the water volume was reduced by an additional factor of 1/5
  • the water volume either was reduced or increased by an additional factor. For example, if, in Step 1 , a significantly quantity of impurities were present in the final product, then the additional scale factor was reduced based on how much impurities were present - e.g. if a small quantity of impurities were present, then a scale factor of 1/4 might be tried, whereas if a large quantity of impurities were present, then a scale factor of 1/3 or 1/2 might be tried. However, if the material was still 100% pure after Step 1 , then a scale factor of 1/6 or higher might be tried.
  • Step 2 was repeated with additional water volume scale factor changes as appropriate .
  • the sample was left covered with aluminum foil in the fume hood to dry. After 2 day air-flow drying, the dried product was obtained as a dark brown powder. The water content of the dried product was measured. The results of the water content measurements are listed in the following table.
  • Theoretical yield calculated for Ag 5 l0 6 was 90% (8.21 g). Experimental yield was 99.6 %. The XRD data indicated that the sample was 100 ⁇ 0 wt% Ag 5 l0 6 .
  • Theoretical yield calculated for Ag 5 l0 6 was 90% (8.21 g). Experimental yield was 93.5 %. The XRD data indicated that the sample was 100 ⁇ 0 wt% Ag 5 l0 6 .
  • Batch 3 small scale as 1/5 of basic scale and the water volume with 1/50 (1/5*1/10) scale factor
  • Theoretical yield of Ag 5 l0 6 was 90% (8.21 g). Experimental yield was 94.0%. The XRD data indicated that the sample was 100 ⁇ 0 wt% Ag 5 l0 6 . Batch 6— basic scale on MOI and the water volume with 1/20 scale factor
  • Theoretical yield calculated for Ag s l0 6 was 90% (41.04 g). Experimental yield was 98.9 %. The XRD data indicated that the sample was 100 ⁇ 0 wt% Ag 5 l0 6 .
  • the dressing pieces were placed on watch glasses in the fume hood (under aluminum foil) until dry.
  • the dressing pieces were stored in sealed glass containers protected from light, and kept cold, until they were used.
  • the autoclave method was the least effective - the 3 ply dressings did not coat adequately to generate zones of inhibition, while the zone size dropped with time for the gauze dressing.
  • the remaining methods all generated dressings with comparable silver contents that made consistent zone of inhibition sizes for 10 days, at which point the study was ended, indicating excellent bacteriostatic longevity. In all cases, the only silver compound present on the dressings was Ag 5 l0 6 .

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Plant Pathology (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Agronomy & Crop Science (AREA)
  • Inorganic Chemistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Dentistry (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to the synthesis of silver(I) orthoperiodates, preferably Ag5IO6. The synthesis process comprises mixing in an aqueous solution a hydroxide, a periodate, and a source of single valency silver ions; and allowing the silver(I) orthoperiodate to form.

Description

METHOD FOR PRODUCING SILVER(I) ORTHOPERIODATES
I. Field of the Invention
This invention relates to methods for producing anti-microbial silver compounds, preferably silver (I) periodates. The invention also includes the silver compounds produced by the process of the invention.
II. Background of the Invention
Silver and silver ions have long been known for their anti-bacterial properties. More recently, this use has extended to treating biofilms and to their incorporation as antimicrobial agents in medical devices and wound dressings.
As the new uses expand, there is a need for more efficient production processes and for the development of new silver-containing antimicrobial agents having improved properties, such as greater stability. There is also a need for antimicrobial compositions that overcome the settling and agglomeration problems of conventional oligodynamic compositions. There is also a need for antimicrobial compositions that are stable and are not readily inactivated in the environment of their intended use.
Processes for producing silver compounds are well known to those of ordinary skill in the art. See for example, Cohen and Atkinson, Inorg. Chem. 3(12) 1741 - 1743 (1964); and Balikungeri, et al, Inorganica Chimica Acta, 22:7-14 (1977).
III. Summary of the Invention
The compositions and methods of the present invention comprise one or more silver (I) periodate compounds or compositions, their methods of synthesis, and their use as antimicrobial agents. This invention provides several methods for producing or synthesizing Ag5l06 and Ag2H3l06.
The compositions and methods of the present invention comprise silver ions or complexes containing silver as the antimicrobial agent. These silver-containing agents are the active agents in antimicrobial compositions. In preferred embodiments of the invention, the silver compounds are one or more silver (I) periodates.
The compositions and methods of the present invention have applicability wherever the presence of an antimicrobial agent is effective and/or beneficial. Without intending to limit the scope of potential uses, these antimicrobial agents may be used in a wide variety of agricultural, industrial, and medical environments, e.g., disinfecting any surface, particularly disinfecting work or processing surfaces (e.g., tables); in antimicrobial coatings; in medical devices and implants, particularly where having an antimicrobial property or characteristic would be beneficial; and in treating human, plant, and animal diseases and conditions. The compositions and methods of the present invention are also effective in treating and/or eradicating biofilm.
An advantage of the compositions and methods of the present invention is that the silver compounds are thermally stable and are not inactivated as quickly as typical ionic silver when placed in contact with compounds that typically inactivate silver ions, e.g., chlorides, sulphides, sulphates, carbonates, thiosulfates, bromides, and iodides. The compounds of the present invention also are not inactivated when exposed to a biological fluid, e.g., urine, feces, mucin, or blood. That is, the silver ions of the present invention retain their antimicrobial activity for periods of time in environments that would typically inactivate other silver containing agents.
IV. Detailed Description of the Invention
The present invention is a process for producing a silver (I) periodate comprising mixing in an aqueous solution a hydroxide; a periodate; and a source of single valency silver ions; and allowing the silver (I) periodate to form. In preferred embodiments of the invention, the hydroxide is potassium hydroxide, the periodate is potassium meta-periodate, or the source of silver is silver nitrate.
The compounds produced by the process of the present invention include, but are not limited to, a silver-containing chemical substance, compound, or complex that exhibits antimicrobial activity, and is Ag (I) combined with a higher oxidation state iodine and coordinated with oxygen atoms. Exemplary compounds include but are not limited to silver (I) periodate; one or more reaction products of a sodium and/or potassium diperiodatoargentate, each of these reaction products containing iodine; pentasilver hexaoxoiodate; Ag5l06; silver orthoperiodate; silver periodate (VII); silver iodate (VII); 5 Ag20°l207; Ag2H3l06; and other combinations of AgxHyl06 where x+y=5; AgxMyl06, where the total cationic charge of x + y = 5 and M is one or more cations; and combinations thereof. One skilled in the art will readily recognize that the cation can be any of a large number of cations. Exemplary cations include but are not limited to K, Na, Mg, Ca, Au, Pt, Cu, Zn, and Fe. The preferred cations are K and Na.
The preferred compounds are Ag5l06 and Ag2H3l06l and compositions containing one or both of these compounds.
In some embodiments of the invention, the compound may be anhydrous or a hydrate.
The compositions and methods of the present invention are antimicrobial, e.g. against biofilms, similar structures, or precursors formed by bacteria, fungi, viruses, algae, parasites, yeasts, and/or other microbes. In some embodiments of the invention, the antimicrobial effectiveness also applies to planktonic microorganisms. The invention also includes an improved process for producing silver compounds, including, but not limited to, the silver (I) periodate compounds of the present invention.
The silver (I) periodate compounds of the present invention may be produced by mixing, in an aqueous solution: 1) a hydroxide; 2) a source of iodine, e.g., a periodate; and 3) a source of silver. In preferred embodiments of the invention, the hydroxide is potassium hydroxide; the source of iodine is potassium meta-periodate; and the source of silver is silver nitrate. One skilled in the art will recognize that various types of water may be used in the processes of the present invention, including but not limited to deionized, reverse osmosis, distilled, double distilled, and milli-q. The preferred water is deionized or double deionized.
The silver (I) periodates of the present invention may be formed by mixing the primary ingredients in any ratio suitable for the specific reagents used and/or for the desired product, e.g., a ratio from about X:Y:Z to about X':Y':Z' (where X and X' is the relative amount of the source of silver; where Y and Y' is the relative amount of the hydroxide; and where Z and Z' is the relative amount of the source of iodine). X, X', Y, Y', Z, and Z' may be integers or any fraction of an integer.
For the production of 100% to near 100% pure Ag5l06, where X:Y:Z is AgNO3.KOH.KIO4, the ratio may be from about 1 :8:2 to about 8:1 :0.5. The preferred ratio range is from about 1 :2.6:0.72 to about 7:2.5:1 , and the most preferred range is from about 1 :1.1 :0.4 to about 1.0.7:0.24.
As shown in Example 3, the inventors have found that 100% pure Ag5l06 may be formed using 5.7 g AgN03, 5.1 g KOH, and 1.8 g KI04, which corresponds to a weight ratio of 1 :0.89:0.32.
The silver (I) periodates of the present invention may be formed by mixing: source of silver, from about 10 grams to about 80 grams; hydroxide, from about 10 grams to about 80 grams; and periodate, from about 5 grams to about 20 grams. One skilled in the art will recognize that the specific amounts used may be scaled up or down from these ranges together based on the amount of product intended to be produced.
In preferred embodiments of the invention, the silver (I) periodates of the present invention may be formed by mixing: source of silver, from about 25 grams to about 70 grams; hydroxide, from about 25 grams to about 65 grams; and periodate, from about 10 grams to about 18 grams.
In the most preferred embodiments of the invention, the silver (I) periodates of the present invention may be formed by mixing: source of silver, from about 40 grams to about 50 grams; hydroxide, from about 35 grams to about 45 grams; and periodate, from about 12 grams to about 16 grams. The amount of each raw material may be scaled up or down from the base quantity by multiplying each base quantity by a standard scale factor (SF). Base quantities that have been found to be effective are: silver nitrate, 45.6 g; potassium hydroxide, 40.8 g; potassium meta-periodate, 14.4 g; and De-ionized water, 250 ml_ It is intended that the present invention should not be limited to these specific amounts; they represent the relative proportions found to be effective using the least amount of silver nitrate in a process in which all of the silver reacted (for cost savings purposes).
This proportion also results in 100% purity product. One skilled in the art will recognize that changing one or more of the proportions may result in all of the silver reacting, but other side reactions may occur (e.g., KN03 formation). For example, decreasing the amount of KOH or KI04 may result in some of the AgN03 not reacting. The invention therefore includes other reactions, e.g., where purity of the resulting product and/or unreacted silver is acceptable.
One skilled in the art will readily recognize that other parameters typical of chemical reactions may variable depending on the specific reagents and the intended product(s). Exemplary other parameters include but are not limited to mixing time, stirring rate, temperature, pressure, drying time, and pH. It is believed that temperature and pressure may not be critical - room temperature and pressure have been shown to be effective in the synthesis processes shown in the Examples. The drying time and method may be related to the consistency of the final product - the final product may hold excess water if not well dried. With lower water volumes, the inventors have found stirring rate and time may affect the final grain size, e.g., a longer stirring time may result in larger grain size.
The inventors have also found that pH does not need to be controlled, and that varying the pH to achieve a desired product is well within the skill in the art. For example, if the process includes KOH and is a highly basic reaction, the typical product is Ag5l06. If KOH is not present and the reaction is acidic/neutral, the product tends to be Ag2H3l06. If the pH is between these two, a mixture of Ag5l06 and Ag2H3l06 tends to be produced.
The inventors have also found that a minimum stirring time is one that is sufficient to ensure that the reaction is complete, a time that is variable depending on the type and amount of reagents. Determining all of these parameters is well known to those with skill in the art.
Some embodiments of the invention include a source of single valency silver ions selected from the group consisting of silver nitrate; any silver compound soluble in aqueous solution; or combinations thereof. In some embodiments, the present invention relates to an article of manufacture which comprises the antimicrobial compositions of the present invention. In one embodiment, the composition is used to form an article or a portion of the article, for example by molding, casting, extruding, etc. Thus, at least part of the formed article is composed of one or more of the compositions of the present invention, alone or in admixture with other components. In another disclosed embodiment, the composition is applied to a preformed article or part of an article as a coating. The coated article may be produced, for example, by dipping the article into the composition or by spraying the article with the composition and then drying the coated article. In one preferred embodiment, the compositions are used to coat medical devices by reaction of one silver iodate (e.g. sodium diperiodatoargentate and/or potassium diperiodatoargentate) to form another (e.g. pentasilver hexaoxoiodate) in the presence of the device to be coated. In another preferred embodiment, the silver iodate is formed from silver nitrate, potassium hydroxide, and potassium meta-periodate in the presence of the device to be coated. In yet another preferred embodiment, the silver iodate is pre-synthesized as a powder using one of the above methods, and is then incorporated into or coated onto the device.
In some embodiments of the invention, the starting compounds used to form the silver iodates are produced by an aqueous solution of a monovalent silver salt or a silver complex such as silver nitrate, in the presence of a periodate such as potassium meta-periodate, with or without potassium hydroxide, depending on the desired silver iodate compound. Inclusion of the base causes formation of compounds such as Ag5l06, while exclusion of the base causes formation of compounds such as Ag2H3l06. Alternately, silver iodates, such as pentasilver hexaoxoiodate, can be formed by hydrothermal reaction of compounds such as sodium or potassium diperiodatoargentate (III), or combinations thereof.
The reaction products of the present invention are typically formed in an aqueous solution. If formed from silver nitrate, potassium meta-periodate, and potassium hydroxide, this reaction can be performed at room temperature. If formed from potassium and/or sodium diperiodatoargentate (III), the reaction rate can be increased by heating the solution. While not intending to limit the invention to a particular temperature or temperature range, the reaction products of the present invention may be formed by heating the solution up to about 400°C, preferably in a range from about room temperature to about 150°C, preferably in a range from about 70°C to about 120°C. One skilled in the art will recognize that other factors, such as pressure, may affect the reaction, and may affect the choice of a particular temperature. For instance, the examples show that the reaction products of the present invention may be formed at 80°C under ambient conditions or may be formed at 120°C under pressure (e.g., in an autoclave).
The silver compositions of the present invention may be used with or incorporated into an article where antimicrobial properties are desirable and/or beneficial. The present invention also may provide compositions that provide antimicrobial, antibacterial, antiviral, or antifungal activity, or some combination thereof. Examples include, but are not limited to, medical and surgical devices and/or environments, such as catheters or implants. Other uses will be readily evident to those skilled in the art.
The methods and compositions of the present invention may be used wherever biofilm or similar structures may be found, including but not limited to microorganisms growing and/or floating in liquid environments, particularly flowing liquids.
Additional inactive ingredients may be optionally incorporated in the formulations, or added to the formulation, based on the intended use. Those skilled in the art will readily recognize that there are a wide variety of additional ingredients that may be added to a composition of the present invention, including but not limited to emulsifiers, thickening agents, solvents, anti-foaming agents, preservatives, fragrances, coloring agents, emollients, fillers, and the like.
Example 1
Operation #1
1. To a clean beaker on top of a magnetic stir plate, equipped with a magnetic stir bar (alternate: overhead stirrer), charge:
De-ionized water: 250 mL x SF = mL
2. Begin agitation of the water with the stirrer assembly.
3. Stirring rate: (e.g. 360 rpm)
(Stirring rate is a function of the batch size and stirrer. The operator may choose a stirring rate that causes the solution to generate a vortex and create an even mixture.)
4. Add 40.8 g x SF = g of potassium hydroxide.
5. Agitate the mixture until all the potassium hydroxide is dissolved.
6. Check the pH of the solution.
Operation #2
1. Add 14.4 g x SF = g potassium meta-periodate .
2. Agitate the mixture until all the potassium meta-periodate is dissolved.
3. Check the pH of the solution. Operation #3
1. Add 45.6g x SF = g silver nitrate to the solution.
2. A brown/black precipitate should form during this step. Operation #4
1. Mix for a minimum of 10 min (up to 2 hours or more can be used for larger scale batches).
2. Stop the magnetic stirrer.
If a larger volume of water is used, the following steps 3-5 are optional additional steps.
3. Allow the Ag5l06 solids to settle for at least 2 hours before decanting. The mixture may be left for up to 24h. There should be no visible suspended particles present in the supernatant.
4. Using a peristaltic pump, decant at least ¾ of the solution.
5. Hold the decanted volume for disposal in Op #10.
Operation #5
1. Using filter paper P2 or equivalent in a Buchner funnel attached to a vacuum apparatus, filter the Ag5l06. A small amount of ddH20 or deionized H20 can be used to wash the solid remaining in the bottom of the flask into the filter.
2. Measure the pH of the filtrate.
3. Hold the filtrate for disposal.
4. Slurry wash the Ag5l06 solid cake on the filter with 200mL x SF = mL deionized or distilled water.
5. Add the wash water to the waste solution containing the filtrate (and decanted waste as appropriate) and hold for disposal.
Operation #6
1. Protecting the filter cake from collecting dust or other foreign objects (e.g. by covering the funnel with paper towel or equivalent), pull dry the filter cake by keeping the system under vacuum for approximately 15 minutes x SF = min. Seal any cracks or channels that form in the filter cake and break up any larger aggregates with a spoonula to assist removal of the water.
Note: The filter cake should be dried (e.g., pulled dry) until no more water comes through the filter and the cake appears relatively dry. This time may be variable, and is typically from about 15 minutes to about the time calculated in step 1. Note: This method should not result in any N03 in the final product. However, if the product shows signs of white crystal formation, the product should be washed with additional ddH20 and re-dried as described above. Operation #7
1. Transfer the Ag5l06 solids to a large watch glass.
2. Cover the watch glass loosely with aluminum foil and place the watch glass in a fume hood to dry overnight. Operation #8
1. Weigh the overnight dried Ag5l06.
2. Perform water content analysis on the overnight dried Ag5l06.
3. If the material is sufficiently dry (average water content is≤ 7000 ppm), proceed to Op# 9.
4. If the water content in the material is >7000 ppm, break up any clumps, and transfer the material to an appropriate sized flask, .protected from light, and attach the flask to the vacuum pump (Configuration: sample-containing flask, then drying column, then neutralization trap, then vacuum pump).
5. Turn on the vacuum pump and allow the sample to dry under vacuum overnight (approximately 24 hours).
6. Transfer the dry product to a suitable (e.g. glass) tared, labeled container, place the container in a clean plastic (e.g. Ziploc) bag.
Operation #9
1. Perform water content analysis on the dried Ag5l06.
2. Determine purity of the product by any appropriate test, e.g., XRD analysis.
Operation #10 ~ Waste Treatment
1. This step may be started while the product is drying.
2. Using pH paper or pH meter and appropriately diluted 65% nitric acid, neutralize the decanted solution to a pH between 6 and 8.
3. Discard neutralized solution down the drain.
Following this method, Ag5l06 yields >95% are consistently achieved with a purity of 100% material being Ag5l06 as determined by XRD. Example 2.
The purpose of this example was to determine whether Ag5l06 synthesized from potassium or sodium diperiodatoargentate (III) and Ag5l06 synthesized directly were of equivalent purity, and to compare their properties.
Methods Developed:
1. Ag5l06 synthesis from sodium diperiodatoargentate (Method 1)
i. 4L of a 5000 ppm solution of sodium diperiodatoargentate in ddH20 was stirred on a magnetic heater/stirrer until dissolved.
ii. The solution was placed in an autoclave and a liquid cycle was run.
Alternatively, the solution can be heated in an oven at, for example, 80°C, at room pressure, but the process takes longer to provide the same material.
iii. The solid material formed via this method was processed as described below:
I. The solution was vacuum filtered using a fine glass crucible filter.
II. An additional 25 mL of ddH20 was added to the sample and drawn through to remove any soluble impurities.
III. The compound was dried under vacuum for 15 minutes.
IV. The sample was placed in a tared watch glass, placed in the fume hood, and covered, but not sealed and left to dry overnight.
V. Any large/hard lumps were broken up with a spoonula.
VI. The sample was transferred into a vial and the vial was stored in a sealed container with a desiccant.
iv. If the solutions after processing using the methods described above were not clear and colorless (i.e. there was visual evidence of silver compounds still present in the solutions), then, for some runs (2 and 3), the filtrate was re-autoclaved and re-processed to see if additional material could be recovered .
2. Ag5l06 synthesis from potassium diperiodatoargentate
i. The same method was used as described in 1 .
Ag5l06 direct synthesis (Method 2)
51 g of KOH was added to 1 L ddH20 and allowed to dissolve.
19g of KI04 were added to the solution, which was stirred at 360 rpm at
RT. iii. 5.7g of AgN03 was added to the solution, which was stirred at 360 rpm at RT for 2h.
iv. The solution was processed as described in Step iii of Method 1 (above). v. If the resulting product showed signs of white crystal formation (KN03), the product was washed with additional ddH20 and re-dried until no white crystals were observed.
Discussion/Conclusions/lmplications:
• All methods produced high purity Ag5l06; however, the direct synthesis method produced at least three times higher yields than the other methods.
• The water content showed that there was between 10 and 200 molecules of Ag5l06 per one molecule of water supporting the fact that Ag5l06 is anhydrous when made by the above methods.
• While SEMs within each sample type looked similar, the Ag5l06 made by each method was distinctly different in terms of physical shape/crystal structure. The direct method made large chunks with fibrous crystal protrusions while the autoclave methods made small crystals that had relatively homogeneous structures.
• Positive aspects of the direct method are that no intermediate compound needs to be made and the process can be completed at room temperature. Furthermore, the direct method yields at least twice the Ag5l06 per molecule of silver used. KN03 impurities needed to be rinsed off with ddH20 to ensure a pure final compound with the ratios of material used in this example. It is possible to reduce NO3 impurity formation by reducing the quantities of KOH and KI04 used to synthesize the Ag5l06, as was shown in Example 1 , where 100% pure material was achieved.
Example 3.
Synthesis Optimization: The purpose of this study was to determine whether direct synthesis of Ag5l06 could be performed with a lower starting concentration of base or KIO4 relative to Example 2.
Run 1
1. 19g of KIO4 was added to 1 L ddH20 and allowed to dissolve.
2. The solution was stirred at 360 rpm at room temperature. The KI0 did not dissolve completely - the solution was filtered and 13.44g undissolved KI04 was collected. 3. 5.7g of AgN03 was added to the solution. The solution was stirred at 360 rpm at room temperature for 2 hours. The precipitate formed was a milky orange-brown color, and then turned light tan.
4. The solution was vacuum filtered.
5. An additional 25 mL of ddH20 was added to the sample and drawn through to remove any soluble impurities. A thin layer on top of the tan colored solids turned dark brown.
6. The compound was dried under vacuum for 15 minutes.
7. The sample was placed in a watch glass in the fume hood to dry overnight, and covered, but not sealed.
8. Any large/hard lumps were broken up with a spoonula.
9. If necessary, the product was washed with additional ddH20 and re-dried as described above until no white crystals were observed.
10. The sample was transferred to a vial and placed into a sealed container with a desiccant.
The product achieved in Run 1 was 97.4 wt% Ag2H3l06 (pale yellow product), and 2.6 wt% Ag5l06 (dark brown product which formed on washing to a higher pH), as determined by XRD.
Run 2
1. The same method as Run 1 was used, except that 5.11g of KOH was dissolved in the ddH20 prior to adding the KI04. The KI04 took longer to dissolve than previous studies where 10x more KOH was used. After AgN03 addition, a dark brown precipitate formed immediately.
The product achieved in Run 2 was 75.6 wt% Ag5l06 and 24.4 wt% unreacted KI04, as determined by XRD. In all cases, the yield was close to 100% of the theoretical yield.
Run 3 (performed in triplicate)
1. The same method as Run 2 was used, except that the KIO4 was reduced to 1.82g, allowing it to dissolve quickly. After AgN03 addition, a dark brown precipitate formed immediately.
The product achieved (all three times) was 100% Agsl06 by XRD. Discussion/Conclusions/Implications:
• Run 1 showed that the formation of Ag5l06 is dependent on the addition of KOH.
In its absence, Ag2H3l06 forms. The dissolution of KI04 also depended on the KOH.
· In Run 2, the KI04 in the final product showed that not all the KI04 reacted to form Ag5l06.
• The adjusted method to synthesize Ag5l06 in Run 3-1 to 3-3 resulted in pure Ag5l06 with equal yield to the Ag5l06 produced in Example 2. The reduction of KOH and KI04 from 51g to 5.1g and 19g to 1.8g, respectively, did not change the product purity or yield, while substantially reducing the cost of the reactants.
For future, it is recommended that the ratio of reagents used should be5.1 g KOH : 1.8g KI04 : 5.7g AgN03. In a separate study, it was determined that the stirring time could be reduced to 10 minutes without impacting the yield or purity.
Example 4
The purpose of this example is to determine whether Ag5l06, currently synthesized following Example 1 , can be made using a lower starting volume of water.
The method that is used in Example 1 may use large volumes of water to generate the Ag5l06. It was determined that significantly reducing the water volume resulted in the presence of KI04, one of the starting products, in the final product, due to its relatively low solubility. Although it initially dissolved at lower water volumes, it appeared that when the AgN03 was added to the solution, the higher ionic strength of the solution caused the KI04 to precipitate out before it had a chance to react with the AgN03. There did appear to be some room for reduction of the starting water volume, which would be very valuable for potential future commercial-scale production. The purpose of this study is to determine how much the starting water volume can be reduced (if at all) without impacting the purity of the final product.
1. A batch was generated following Example 1 at a scale factor of 1/5 (i.e. starting with 9.12g AgN03, etc.), but the water volume was reduced by an additional factor of 1/5
(i.e. 208 mL).
2. Based on the results of Step 1 , the water volume either was reduced or increased by an additional factor. For example, if, in Step 1 , a significantly quantity of impurities were present in the final product, then the additional scale factor was reduced based on how much impurities were present - e.g. if a small quantity of impurities were present, then a scale factor of 1/4 might be tried, whereas if a large quantity of impurities were present, then a scale factor of 1/3 or 1/2 might be tried. However, if the material was still 100% pure after Step 1 , then a scale factor of 1/6 or higher might be tried.
3. Step 2 was repeated with additional water volume scale factor changes as appropriate .
4. Once an additional scale factor for water volume was determined that appeared to be optimal in terms of the least water required while still generating an acceptable level of yield and purity in the final product, two more batches was generated to ensure consistency. At least one of these batches was generated at a larger scale, i.e. the base scale, to ensure that the process was scalable at the lower water content.
Batch 1— small scale as 1/5 of basic scale and the water volume with 1/25 (1/5*1/5) scale factor
In a clean 0.5 L beaker, 8.16 g of KOH was added to 200 mL ddH20. After KOH dissolved, 2.88 g of KI04 was added. The solution was stirred at 360 rpm. After KI04 dissolved, 9.12 g of AgN03 was added slowly. A brown precipitate immediately formed resembling Ag5l06. The solution was stirred for 2 hrs. After that, the material was left to settle overnight to facilitate filtration. The next day, the solution was filtered with a crucible filter. The solid sample collected in the filter was washed with 40 mL ddH20. The sample was dried under vacuum for 15 min. During this period, the solid cake was smoothed with a spatula to close the tiny channels forming on the surface. The sample was transferred to a watch glass. This wet product was weighed as follow:
Watch glass: 131.03 g
Wet weight and watch glass: 140.26 g
Wet product: 9.23 g
The sample was left covered with aluminum foil in the fume hood to dry. After 2 day air-flow drying, the dried product was obtained as a dark brown powder. The water content of the dried product was measured. The results of the water content measurements are listed in the following table.
Table 1. Water content of samples in batch 1.
Figure imgf000015_0001
2 0.1002 7589.8
3 0.1005 6583.1
4 0.1007 5146.0
Average (ppm)* - 6439.6
*The average of water content was calculated by the last three measurements
(2-4)
Watch glass + dry sample: 138.21 g
Dry sample: 8.18
Theoretical yield calculated for Ag5l06 was 90% (8.21 g). Experimental yield was 99.6 %. The XRD data indicated that the sample was 100±0 wt% Ag5l06.
Batch 2— small scale as 1/5 of basic scale and the water volume with 1/40 (1/5*1/8) scale factor
The results obtained for batch 1 indicated that the water volume scale factor could be reduced. Thus, in a clean 0.3 L beaker, 8.16 g of KOH was added to 125 mL ddH20. After KOH dissolved, 2.88 g of KI04 was added. The solution was stirred at 360 rpm. After KI04 dissolved, 9.13 g of AgN03 was added slowly. A brown precipitate immediately formed resembling Ag5l06. The solution was stirred for 2 hrs. After that, the material was left to settle overnight in order to facilitate filtration. The next day, the solution was filtered with a crucible filter. The solid sample collected in the filter was washed with 40 mL ddH20. The sample was dried under vacuum for 15 min. During this period, the solid cake was smoothed with a spatula to close the tiny channels forming on the surface. The sample was transferred to a watch glass. This wet product was weighed as follow: Watch glass: 39.36 g; Wet weight and watch glass: 48.65 g; Wet product: 9.29 g.
The sample was left covered with aluminum foil in the fume hood to dry by air-flow overnight. The next morning, the dried product obtained was a dark brown powder. The water content of the dried product was measured. The results of the water content measurements are listed in the following table. Table 2. Water content of samples in batch 2.
Figure imgf000016_0001
2 0.1011 1124.6
3 0.1012 1169.0
Average (ppm) - 1158.7
Watch glass + dry sample: 47.04 g
Dry sample: 7.68 g
Theoretical yield calculated for Ag5l06 was 90% (8.21 g). Experimental yield was 93.5 %. The XRD data indicated that the sample was 100±0 wt% Ag5l06.
Batch 3— small scale as 1/5 of basic scale and the water volume with 1/50 (1/5*1/10) scale factor
The results obtained for batch 2 indicated that the water volume scale factor could be further reduced by an additional scale factor. In a clean 0.3 L beaker, 8.16 g of KOH was added to 100 mL ddH20. After KOH dissolved, 2.88 g of KI04 was added. The solution was stirred at 360 rpm. After KI0 dissolved, 9.12 g of AgN03 was added slowly. A brown precipitate immediately formed resembling Ag5l06. The solution was stirred for 2 hrs. After that, the material was left to settle overnight. The next day, the solution was filtered with a crucible filter. The solid sample collected in the filter was washed with 40 mL ddH20. The sample was dried under vacuum for 15 min. During this period, the solid cake was smoothed with a spatula to close the tiny channels forming on the surface. The sample was transferred to a watch glass. This wet product was weighed as follow: Watch glass: 39.21 g; Wet weight and watch glass: 47.91 g; Wet product: 8.70 g
The sample was left covered with aluminum foil in the fume hood to dry by air-flow overnight. The next morning, the dried product obtained was as a dark brown powder. The water content of the dried product was measured. The results of the water content measurements are listed in the following table. Table 3. Water content of samples in batch 3.
Figure imgf000017_0001
2 0.1011 664.7
3 0.1004 802.8
Average (ppm) 758.4
Watch glass + dry sample: 46.69 g
Dry sample: 7.48 g
Theoretical yield calculated for Ag5l06 was 90% (8.21 g). Experimental yield was 91.1%. The XRD data indicated that the sample was 100±0 wt% Ag5l06. Batch 4— small scale as 1/5 of basic scale and the water volume with 1/100 (1/5*1/20) scale factor
The results obtained in run 3 indicated that the water volume for the reaction can be reduced even further. In a clean 0.125 L beaker, 8.16 g of KOH was added to 50 mL ddH20. After KOH dissolved, 2.89 g of KI04 was added. The solution was stirred at 360 rpm. After KI04 dissolved, 9.13 g of AgN03 was added slowly. A brown precipitate immediately formed resembling Ag5l06. The solution was stirred for 2 hrs. After that, the material was left to settle overnight. The next day, the solution was filtered with a crucible filter. The solid sample collected in the filter was washed with 40 mL ddH20. The sample was dried under vacuum for 15 min. During this period, the solid cake was smoothed with a spatula to close the tiny channels forming on the surface. The sample was transferred to a watch glass. This wet product was weighed as follow: Watch glass: 39.20 g; Wet weight and watch glass: 48.99 g; Wet product: 9.79 g
The sample was left covered with aluminum foil in the fume hood to dry by air-flow overnight. The next morning, the dried product obtained was a dark brown powder. The water content of the dried product was measured. The results of the water content measurements are listed in the following table. Table 4. Water content of samples in batch 4.
Figure imgf000018_0001
2 0.1013 5253.7
3 0.1011 5024.7
Average (ppm) 5429.4
Watch glass + dry sample: 47.12g
Dry sample: 7.92 g
Theoretical yield of Ag5l06 was 90% (8.21 g). Experimental yield was 96.4%. The XRD data indicated that the sample was 100±0 wt% Ag5l06. Batch 5— small scale as 1/5 of basic scale and the water volume with 1/100 (1/5*1/20) scale factor
At this point it was decided that the water volume scale was low enough therefore reducing the water volume was not considered. For this batch, batch 4 was repeated to warranty consistency.
In a clean 0.125 L beaker, 8.16 g of KOH was added to 50 ml_ ddH20. After KOH dissolved, 2.89 g of KI04 was added. The solution was stirred at 360 rpm. After KI04 dissolved, 9.12 g of AgN03 was added slowly. A brown precipitate immediately formed resembling Ag5l06. The solution was stirred for 2 hrs. After that, the material was left to settle overnight. The next day, the solution was filtered with a crucible filter. The solid sample collected in the filter was washed with 40 mL ddH20. The sample was dried under vacuum for 15 min. During this period, the solid cake was smoothed with a spatula to close the tiny channels forming on the surface. The sample was transferred to a watch glass. This wet product was weighed as follow: Watch glass: 39.36 g; Wet weight and watch glass: 48.67 g; Wet product: 9.31 g
The sample was left covered with aluminum foil in the fume hood to dry by air-flow overnight. The next morning, the dried product obtained was a dark brown powder. The water content of the dried product was measured. The results of the water content measurements are listed in the following table. Table 5. Water content of samples in batch 5.
Figure imgf000019_0001
2 0.1028 5287.0
3 0.1022 4761.3
Average (ppm) - 4962.7
Watch glass + dry sample: 47.08 g
Dry sample: 7.72 g
Theoretical yield of Ag5l06 was 90% (8.21 g). Experimental yield was 94.0%. The XRD data indicated that the sample was 100±0 wt% Ag5l06. Batch 6— basic scale on MOI and the water volume with 1/20 scale factor
Batch of Ag5l064 and 5 gave consistent results of 100% purity (XRD) and yields of 94-96.4%, indicating that the water volume factor of 1/20 did not have a negative impact on the purity and yield of Ag5l06 production. For this particular batch, a large scale was generated to ensure that the process was scalable with 1/20 water volume factor.
In a clean 0.5 L beaker, 40.8 g of KOH was added to 250 mL ddH20. After KOH dissolved, 14.41 g of KI04 was added. The solution was stirred at 360 rpm. After KI04 dissolved, 45.6 g of AgN03 was added slowly. A brown precipitate immediately formed resembling Ag5l06. The solution was stirred for 2 hrs. After that, the material was left to settle overnight. The next day, the solution was filtered with a crucible filter. The solid sample collected in the filter was washed with 40 mL ddH20. The sample was dried under vacuum for 15 min. During this period, the solid cake was smoothed with a spatula to close the tiny channels forming on the surface. The sample was transferred to a watch glass. This wet product was weighed as follow: Watch glass: 131.34 g; Wet weight and watch glass: 182.6 g; Wet product: 51.26 g
The sample was left covered with aluminum foil in the fume hood to dry by air-flow overnight. The next morning, the dried product obtained was a dark brown powder. The water content of the dried product was measured. The results of the water content measurements are listed in the following table. Watch glass + dry sample: 171.92 g; Dry sample: 40.58 g
Theoretical yield calculated for Agsl06 was 90% (41.04 g). Experimental yield was 98.9 %. The XRD data indicated that the sample was 100±0 wt% Ag5l06.
Table 6. Water content of samples in batch 6.
Figure imgf000020_0001
2 0.1019 3102.1
3 0.1024 2873.0
Average (ppm) 3057.0
During the reactions, the pH of the solution in all of batches 1-6 was higher than 14 at all times. The step of decanting supernatant described in MOI was not considered because the water volume was too low to be decanted. The water content of Ag5l06 obtained in batch 2 and 3 were lower in comparison to the other batches.
The table below showed a comparison of purity, yield and crystallite size of final product (Ag5l06) obtained from each batch.
Table 7. Purity, yield, and crystallite size of Ag5l06 from each batch.
Figure imgf000020_0002
From batch 1 to 5, Ag5l06 was generated at a scale factor of 1/5 with an additional water volume scale factor. In batch 1 , the water volume factor was 1/5*1/5. Ag5l06 was obtained in 100% purity and 99.6 % yield. This result showed that further reduction of the water volume could be considered. In the batches 2 and 3, the water volume scale was reduced consecutively. The additional water volume scale factors 1/8 and 1/10 were applied respectively. The purity of Ag5l06 for both batches was 100% and the yields were 93.5% and 91.1 % respectively. Encouraged by these results, the water volume was further reduced with 1/20 volume factor. Ag5l06 produced in this batch had a purity of 100% and a yield of 96.4%. In fact, the water volume can be reduced further. But 1/20 scale factor was enough to satisfy the scale-up production. Batch 5 (repeated as per batch 4) produced Ag5l06 with 100% purity and a yield of 94.0%. These results were similar to the one obtained in batch 4. This indicated that the water volume scale factor of 1/20 did not have a negative impact on the purity and yield of the product for small scale.
For batch 6, Ag5l06 was scaled-up with the water volume scale factor determined in batch 4 and 5. The batch 6 gives Ag5l06 with 100% purity and 98.9% yield. This demonstrated that reducing water volume to 1/20 scale factor resulted in pure Ag5l06 with equal yield to the one produced with original water volume.
Although the water volume can be reduced without impacting the purity and yield of the final product in this study, it is observed that the crystallite size increased slightly. The crystallites sizes of Ag5l06 derived from experiments with original volume are in the range of 12 A to 29 A whereas the ones generated using a lower water volume factor in the reaction produced slightly bigger crystallites sizes (Table 7). As for now, there is no evidence indicating that increasing the crystallite sizes of Ag5l06 may differ in its ongoing and future applications.
In summary, these results proved that the water volume can be reduced to 1/20 of the original volume based on MOI without negatively impacting the purity and yield of Ag5l06; improving the commercial-scale value of Ag5l06 production in the future.
Example 5
Dressings Coated
• Gauze sponges - 100% cotton
• 3-ply dressings - rayon/polyester core with upper and lower HDPE layers
· Tensoplast™ - rayon/cotton with adhesive
Coating Methods
1. Coating During Synthesis of Ag5l06 from sodium diperiodatoargentate(lll)
A. 500 mL of a 5000 ppm solution of sodium diperiodatoargentate was made in ddH20 and stirred on a magnetic heater/stirrer until the sodium diperiodatoargentate had dissolved. B. 1 in2 pieces of dressing (or larger, as appropriate) were aseptically cut and suspended in the solution with the use of string or the dressing's adhesive.
C. The solution was placed in an autoclave and a liquid cycle was run.
D. After autoclaving, the dressing pieces were removed from the solutions aseptically using forceps and were allowed to drip back into the solution for 30 seconds.
E. The dressing pieces were placed on watch glasses in the fume hood (under aluminum foil) until dry.
F. The dressing pieces were stored in sealed glass containers protected from light, and kept cold, until they were used.
2. Coating During Direct Synthesis of Ag5l06
A. 51 g of KOH was added to 1L ddH20 and allowed to dissolve.
19g of KIO4 was added to the solution. The solution was stirred at 360 rpm at RT.
B. 1 in2 pieces of dressing (or larger, as appropriate) were aseptically cut and placed in the solution, suspended using string, or the dressing's adhesive.
C. After the KI04 was dissolved completely, 5.7g of AgN03 was added to the solution. The solution was stirred at 360 rpm at room temperature for approximately 3 hours.
D. The dressing pieces were removed from the solutions, dried and stored as described in 1.
E. If KNO3 appeared to have formed on the dressings (white crystals) after drying, the dressings were briefly dipped in ddH20 and re-dried as described in 1.
Note: For some dressings, the dressings were dipped prior to drying to remove KNO3, while for other dressings, the dressings were dipped as described in E. 3. Incorporation into Dressings Post-Synthesis
A. 5g of previously made Ag5l06 was ground to a fine powder using a mortar and pestle (or equivalent, e.g. Spex machine) and then added to 1L ddH20. The slurry was stirred at approximately 360 rpm.
B. 1in2 pieces (or larger, as appropriate) of dressing were aseptically cut. The pieces were placed or suspended (using string or the dressing's adhesive) in the slurry for 15 minutes at room temperature (or longer - up to 2 or 3 hours as appropriate) with stirring (e.g. with a magnetic stirrer on a heater/stirrer).
C. If large chunks of Ag5l06 formed during stirring, they were broken up (e.g. with a spoonula) so that they slurried properly.
D. The pieces were then removed from solution using clean forceps, dried, and stored as described in Method 1. Discussion/Conclusions/Implications
• Of the coating methods, the autoclave method was the least effective - the 3 ply dressings did not coat adequately to generate zones of inhibition, while the zone size dropped with time for the gauze dressing. The remaining methods all generated dressings with comparable silver contents that made consistent zone of inhibition sizes for 10 days, at which point the study was ended, indicating excellent bacteriostatic longevity. In all cases, the only silver compound present on the dressings was Ag5l06.
Example 6.
We have also coated metals and beans using variations on the process described above, as appropriate to the specific materials. For the metals, we put the metal pieces in a round bottomed flask and used an overhead stirrer, but otherwise the method was the same. For the beans, we made a slurry of Ag5l06 in water, injected a portion of it with the beans in a Falcon tube, and then closed the Falcon tube, and spun the beans around until they were coated.
We obtained coated metals and coated beans, both of which were shown to exhibit anti-microbial activity stemming from the coating.
While the invention has been described in some detail by way of illustration and example, it should be understood that the invention is susceptible to various modifications and alternative forms, and is not restricted to the specific embodiments set forth in the Examples. It should be understood that these specific embodiments are not intended to limit the invention but, on the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the invention.

Claims

IN THE CLAIMS: We claim:
1. A process for producing a silver (I) periodate comprising mixing in an aqueous solution a hydroxide; a periodate; and a source of single valency silver ions; and allowing the silver (I) periodate to form.
2. The process of claim 1 wherein the hydroxide is potassium hydroxide, the periodate is potassium meta-periodate, or the source of silver is silver nitrate.
3. The process of claim 1 wherein the silver (I) periodate that is formed is selected from the group consisting of pentasilver hexaoxoiodate; Ag5l06; silver orthoperiodate; silver periodate (VII); silver iodate (VII); 5 Ag20°l207; Ag2H3l06; and other combinations of AgxHyl06 where x+y=5; AgxMyl06, where the total cationic charge of x + y = 5 and M is one or more cations; and combinations thereof.
4. A process for synthesizing a silver (I) periodate comprising dissolving a hydroxide in water; adding a meta-periodate and stirring the resulting solution; adding a source of silver ions, and stirring the resulting slurry; and drying the filtered product, thereby producing a silver (I) periodate powder.
5. A method for coating a surface with at least one antimicrobial compound or complex comprising synthesizing a material of claim 2 following a process such as claim 4 in the presence of the surface, thus causing the material to coat onto or be incorporated into the surface.
6. The process of claim 5 wherein the surface is one or more surfaces selected from the group consisting of wound dressings, metals, plants or plant parts, seeds, medical devices, medical instruments, and veterinary devices and instruments.
7. A method of coating a surface with at least one antimicrobial compound or complex of claim 2 comprising first synthesizing the material of claim 2 following a process such as claim 4, and then contacting the formed material with the surface, thus causing the material to coat onto or be incorporated into the surface.
8. The process of claim 1 wherein the process produces a silver compound having a purity up to about 100% pure.
9. The process of claim 1 wherein the process yields from about 95% to about 100% silver compound.
10. The process of claim 1 wherein the source of silver ions, the hydroxide, and the periodate are mixed in a ratio from about X:Y:Z to about X':Y':Z' (where X and X' is the relative amount of the source of silver; where Y and Y' is the relative amount of the hydroxide; and where Z and Z' is the relative amount of the source of iodine). X, X', Y, Y', Z, and Z' may be integers or any fraction of an integer.
1 1. The process of claim 10 for the production of Ag5l06, where the ratio is from about 1 :8:2 to about 8:1 :0.5.
12. The process of claim 11 for the production of Ag5l06, where the ratio is from about is from about 1 :2.6:0.72 to about 7:2.5:1.
13. The process of claim 1 1 for the production of Ag5l06, where the ratio is from about is from about 1 :1 .1 :0.4 to about 1 : 0.7:0.24.
14. The process of claim 1 1 for the production of pure Ag5l06, where the ratio is 1 :0.89:0.32.
15. The process of claim 1 for the production of pure Ag5l06, where uses 5.7 g AgN03, 5.1 g KOH, and 1.8 g KI04.
16. The process of claim 7 wherein the surface is one or more surfaces selected from the group consisting of wound dressings, metals, plants or plant parts, seeds, medical devices, medical instruments, and veterinary devices and instruments.
PCT/CA2013/000735 2012-08-22 2013-08-22 Method for producing silver(i) orthoperiodates WO2014029013A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261691885P 2012-08-22 2012-08-22
US61/691,885 2012-08-22

Publications (1)

Publication Number Publication Date
WO2014029013A1 true WO2014029013A1 (en) 2014-02-27

Family

ID=50149308

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA2013/000735 WO2014029013A1 (en) 2012-08-22 2013-08-22 Method for producing silver(i) orthoperiodates

Country Status (1)

Country Link
WO (1) WO2014029013A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020206555A1 (en) * 2019-04-09 2020-10-15 Exciton Pharma Corp. Preparation of soluble compounds

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120058169A1 (en) * 2010-08-20 2012-03-08 Olson Merle E Silver Iodate Compounds Having Antimicrobial Properties

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120058169A1 (en) * 2010-08-20 2012-03-08 Olson Merle E Silver Iodate Compounds Having Antimicrobial Properties

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
KIMMINS, C. W.: "XXXIV - Contributions from the laboratory of Gonville and Caius College, Cambridge. No. IX.", JOURNAL OF THE CHEMICAL SOCIETY, TRANSACTIONS, vol. 51, 1887, pages 356 - 361 *
LAMANI, S. D. ET AL.: "Mechanistic Investigation on the oxidation of kinetin by Ag(III) periodate complex in aqueous alkaline media: a kinetic approach.", JOURNAL OF CHEMICAL SCIENCES, vol. 122, no. 6, 2010, pages 891 - 900 *
MALODE, S. J. ET AL.: "Mechanistic Investigations on the oxidation of L-valine by Ag(III) periodate complex in alkali media: a kinetic approach.", ACTA CHIMICA SLOVENICA, vol. 56, 2009, pages 936 - 945 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020206555A1 (en) * 2019-04-09 2020-10-15 Exciton Pharma Corp. Preparation of soluble compounds

Similar Documents

Publication Publication Date Title
JP5639586B2 (en) Antibacterial silver solution
EA030761B1 (en) Process for preparing an antimicrobial particulate composition
US9801385B2 (en) Antimicrobial chemical compositions
Vukomanovic et al. The growth of silver nanoparticles and their combination with hydroxyapatite to form composites via a sonochemical approach
CN1310589C (en) Method for preparing superfine composite inorganic antimicrobial agent
Murugesan et al. Fabrication and characterization of strontium substituted chitosan modify hydroxyapatite for biomedical applications
AU2017203415A1 (en) Antimicrobial chemical compositions
WO2014029013A1 (en) Method for producing silver(i) orthoperiodates
Alghonaim et al. Green synthesis of bimetallic Se@ TiO2NPs and their formulation into biopolymers and their utilization as antimicrobial, anti-diabetic, antioxidant, and healing agent in vitro
US9955700B2 (en) Antimicrobial chemical compositions
Sklyar et al. Easily obtained iodine and silver-iodine doped chitosan for medical and other applications
JPH03145410A (en) Antimicrobial silver zeolite and antimicrobial polymer composition free from change of color
EP3714692A1 (en) Antibacterial colloid and method for manufacturing the same
JPH0446106A (en) Fungicidal composition for agriculture and horticulture
Ali et al. Green synthesis of nano binary oxide SiO2/V2O5 NPs integrated ointment cream application on wound dressings and skin cancer cells
JP3467447B2 (en) Inorganic antibacterial material using calcium silicates
JPH02111709A (en) Powdery antibacterial and antimycotic agent and production thereof
JPH0768094B2 (en) Antibacterial and antifungal intercalation compound and method for producing the same
DE894896C (en) Silver-containing germicides
CN117659222A (en) Antibacterial post-treatment liquid of alginic acid grafted tert-butylamine and preparation method thereof
Shekede Bactericidal efficacy of wound gauze treated with chitosan nanomaterial hybrids of zinc, silver and copper on common wound bacteria
US6403050B1 (en) Calcium silicates, a production process thereof, and an inorganic antibacterial material using the same
JPH04273803A (en) Antimicrobial agent
Petkes et al. SYNTHESYS AND CHARACTERIZATION OF SILVER-DOPED HYDROXYAPATITE.
KR20220123952A (en) Silver ion anti-oxidation processing method and silver ion antibacterial solution production method Silver ion antibacterial solution and silver ion-containing products containing the antibacterial solution

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13831210

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13831210

Country of ref document: EP

Kind code of ref document: A1